José F Rodríguez-Orengo

Author PubWeight™ 8.38^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy.	J Hepatol	2005	2.27
2	The glutathione biosynthetic pathway of Plasmodium is essential for mosquito transmission.	PLoS Pathog	2009	1.28
3	Self-reported physical activity in Hispanic adults living with HIV: comparison with accelerometer and pedometer.	J Assoc Nurses AIDS Care	2008	0.93
4	Characteristics of inmates witnessing overdose events in prison: implications for prevention in the correctional setting.	Harm Reduct J	2009	0.84
5	Efficacy and safety of peg-IFN alfa-2a with ribavirin for the treatment of HCV/HIV coinfected patients who failed previous IFN based therapy.	J Clin Virol	2006	0.82
6	Effect of hepatitis C virus treatment in fibrosis progression rate (FPR) and time to cirrhosis (TTC) in patients co-infected with human immunodeficiency virus: a paired liver biopsy study.	J Hepatol	2007	0.79
7	Clinical challenges and controversies in the management of HIV/ HCV-coinfected individuals.	P R Health Sci J	2004	0.78
8	High eradication rates of Helicobacter pylori infection with first- and second-line combination of esomeprazole, tetracycline, and metronidazole in patients allergic to penicillin.	Dig Dis Sci	2005	0.77
9	Rapid quantification of resveratrol in mouse plasma by ultra high pressure liquid chromatography (UPLC) coupled to tandem mass spectrometry.	P R Health Sci J	2014	0.75